Immunogen reported $309.51M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US USD 122.45M 33.91M
Amgen AMGN:US USD 9.5B 4.3B
Astellas Pharma 4503:JP JPY 361.07B 48.06B
AstraZeneca AZN:LN USD 4.46B 359M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Eli Lilly And LLY:US USD 2.62B 5.5M
Emergent Biosolutions EBS:US USD 240.9M 117.2M
Exelixis EXEL:US USD 675.29M 48.29M
Halozyme Therapeutics HALO:US USD 147.16M 56.23M
Heron Therapeutics HRTX:US USD 50.44M 1.83M
Immunogen IMGN:US USD 309.51M 64.36M
Intrexon XON:US USD 9.07M 34.78M
Karyopharm Therapeutics KPTI:US USD 71.35M 10.9M
Macrogenics MGNX:US USD 83.99M 62.52M
Nektar Therapeutics NKTR:US USD 105.76M 28.21M
Novartis NVS:US USD 8.73B 5.1B
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Roche Holding ROG:VX 4.32B 2.54B
Seattle Genetics SGEN:US USD 362.6M 2.27M